Our network pharmacology analysis revealed SJS treated sepsis through multiple pathways and multiple targets, including NF-kB pathway, TNF signaling pathway and IL-17 signaling pathway, which is reported to be closely related to the inflammation and immunity. This evidence concerns the gene IL17A and Sepsis.